Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q3 2013 · 10-Q
Revenue—
Net Income$30.00K$30.00K−93.3% vs Q3 2012 EPS Diluted$0.00$0.00— vs Q3 2012 Operating Income$26,000N/M Operating Cash Flowderived-$6,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 1, 2013 · 32 d after period end